Brain Biotech Group: Advanced Enzyme and Protein Biotechnology

Brain Biotech Group: Advanced Enzyme and Protein Biotechnology

Integrated Solutions for Innovative Enzymes, Proteins and Biobased Manufacturing

We draw inspiration for our innovations from nature's biodiversity. Microorganisms and their enzymes provide us with unique opportunities to develop sustainable and scalable solutions for tomorrow's markets.

As a specialist in industrial biotechnology, we support companies in the food & beverage, life science and environmental sectors.

  • We develop and manufacture specialist enzymes and high-performance production strains.
  • We optimize bioprocesses for industrial-scale manufacturing.

Our solutions improve product quality, increase process efficiency and reduce environmental impact.

Product Portfolio

We offer a broad portfolio of enzyme products and ingredients, primarily for the food and life science industries. Our range includes several hundred products designed for industrial applications and consistent performance at scale.

Learn more about our  Products

R&D Services

We develop innovative, tailored enzymes and protein solutions, as well as bioprocesses for large-scale production.

Learn more about our R&D Services

End-to-end Services for Industry

Within BRAINBiocatalysts, we provide integrated CDMO services by combining:

  • enzyme discovery and engineering
  • strain development
  • process optimization and scale-up

This end-to-end approach ensures efficient transfer from research to industrial production.

Learn more about our Fermentation services

Who is behind the BRAIN Biotech Group?

BRAIN Biotech AG is the parent company of the Group.

The business is organized into two core segments:

  • BRAINBiocatalysts: development, production and distribution of specialty enzymes, microorganisms and ingredients
  • BRAINBioIncubator: research-driven development projects, including pharmaceutical applications

The Group operates production facilities in the UK, continental Europe and the United States, ensuring global manufacturing capabilities.

In fiscal year 2024/25, approximately 280 employees generated revenues of EUR 49.6 million.

Learn more about the Corporate History of BRAIN Biotech AG